MERCK
About
Job Description
In this role, the chosen candidate will work with a team of scientists tasked with identifying, developing, and deploying data-rich technologies aimed at improving the manner in which process understanding is gathered. The tools that we develop are as diverse as the team developing them, and in this Senior Scientist role, the chosen candidate will leverage fundamental process modeling, machine learning, and other innovative data science approaches to enable our process researc...
Updates & Highlights
Some Investors May Be Willing To Look Past Merck KGaA's (ETR:MRK) Soft Earnings
Some Investors May Be Willing To Look Past Merck KGaA's (ETR:MRK) Soft Earnings
Yahoo Finance · about 17 hours ago
Harpoon Therapeutics stock (US4135961044): what Merck’s takeover means for biotech investors
Harpoon Therapeutics stock (US4135961044): what Merck’s takeover means for biotech investors
AD HOC NEWS · about 18 hours ago
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results
Yahoo Finance · 1 day ago
Recent Openings
View all 2 jobsAll Jobs
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
401(k) Match
Retirement savings
Competitive Salary
Market-rate compensation
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Merck?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentSome Investors May Be Willing To Look Past Merck KGaA's (ETR:MRK) Soft Earnings
Some Investors May Be Willing To Look Past Merck KGaA's (ETR:MRK) Soft Earnings
Yahoo Finance · about 17 hours ago
Harpoon Therapeutics stock (US4135961044): what Merck’s takeover means for biotech investors
Harpoon Therapeutics stock (US4135961044): what Merck’s takeover means for biotech investors
AD HOC NEWS · about 18 hours ago
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results
Yahoo Finance · 1 day ago
Merck and eschbach's PMWS Workshop Accelerates Pharma Execution via the "Intelligent Visual Factory"
Merck and eschbach's PMWS Workshop Accelerates Pharma Execution via the "Intelligent Visual Factory"
PR Newswire · 1 day ago
Merck’s Sacituzumab Tirumotecan Data Reframes Outlook For Oncology And Valuation
Merck’s Sacituzumab Tirumotecan Data Reframes Outlook For Oncology And Valuation
Yahoo Finance · 2 days ago
Recon: White House adds Amazon, GoodRx, and Cost Plus to TrumpRx; Merck reports survival benefit in late-stage uterine cancer study
Recon: White House adds Amazon, GoodRx, and Cost Plus to TrumpRx; Merck reports survival benefit in late-stage uterine cancer study
RAPS.org · 2 days ago
Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer
Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer
BioSpace · 2 days ago
Merck inks Keytruda supply pact to support Exelixis cancer trial
Merck inks Keytruda supply pact to support Exelixis cancer trial
Fierce Biotech · 2 days ago
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer
BioSpace · 2 days ago
Regeneron Stock Sinks as Key Melanoma Drug Trial Fails to Beat Merck’s Keytruda
Regeneron Stock Sinks as Key Melanoma Drug Trial Fails to Beat Merck’s Keytruda
Barron's · 3 days ago
Merck claims its first pivotal sacituzumab win | ApexOnco - Clinical Trials news and analysis
Merck claims its first pivotal sacituzumab win | ApexOnco - Clinical Trials news and analysis
Oncology Pipeline · 3 days ago
Merck ADC, licensed from China, hits mark in first big global trial
Merck ADC, licensed from China, hits mark in first big global trial
BioPharma Dive · 3 days ago
Merck, Kelun score with sac-TMT in endometrial cancer trial
Merck, Kelun score with sac-TMT in endometrial cancer trial
Fierce Pharma · 3 days ago
Merck's drug helps uterine cancer patients live longer in late-stage trial
Merck's drug helps uterine cancer patients live longer in late-stage trial
Reuters · 3 days ago
Merck & Co.'s first pivotal study of sac-TMT comes up trumps
Merck & Co.'s first pivotal study of sac-TMT comes up trumps
FirstWord Pharma · 3 days ago
Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3
Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3
BioSpace · 3 days ago
Regeneron faces Wall Street downgrades after high-profile melanoma drug fails to beat Merck's Keytruda
Regeneron faces Wall Street downgrades after high-profile melanoma drug fails to beat Merck's Keytruda
Proactive financial news · 4 days ago
Merck Foundation advances Healthcare Capacity through 2600+ Medical Scholarships across 52 Countries with African and Asian First Ladies
Merck Foundation advances Healthcare Capacity through 2600+ Medical Scholarships across 52 Countries with African and Asian First Ladies
Social News XYZ · 5 days ago
Financial Security Advisor Inc. Raises Holdings in Merck & Co., Inc. $MRK
Financial Security Advisor Inc. Raises Holdings in Merck & Co., Inc. $MRK
MarketBeat · 5 days ago
Lockheed Martin Investment Management Co. Has $9.87 Million Stock Holdings in Merck & Co., Inc. $MRK
Lockheed Martin Investment Management Co. Has $9.87 Million Stock Holdings in Merck & Co., Inc. $MRK
MarketBeat · 5 days ago